The returned product was subjected to a detailed technical analysis and the corresponding product release documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.In addition, the angiographic material provided was reviewed.The technical investigation revealed that the outer shaft has been fully retracted, and that the stent has been fully released.The shaft dimensions comply with the specification.Inspection of the instrument revealed no damage or irregularity besides a kink in the device shaft at the distal end of the handle lever.The angiographic material provided shows the complaint stent after release located distally to the target lesion.A second stent is then implanted proximally overlapping the complaint stent.The actual complaint event is not visible.The angiographic material does therefore not provide any further relevant information with regards to the root cause of the complaint.Review of the product release documentation confirmed that the device in question was manufactured according to specifications and successfully passed all in-process controls as well as the final inspection.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.Please note that the corresponding ifu advises the user to select an appropriate stent size based on the diameter of the artery adjacent to the lesion.In addition, any slack in the delivery system outside the patient could result in incorrect stent placement, potential stent compression or elongation.Finally, it should be noted that pulsar-18 t3 is indicated for use in patients with atherosclerotic disease of the superficial femoral, proximal popliteal and infrapopliteal arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (pta), e.G.Residual stenosis and dissection.
|